Skip to content
J

Jalawi Talal A. Alotaibi

Publications (2)

Overview on Sclerodermal Renal Crisis

Mahdi Ali M. Alyami, Jalawi Talal A. Alotaibi, Shahad Saad A. Aljoaid, Tariq Bander F. Alanazi, Waleed Farhan D. Alshammari, Nuwayr Hamdan D. Albalawi, Reema Abdulrahman A. Alanazi, Abrar Ali M. Aldhameen, Muflih Abdullah S. Albalawi, Mona Khalid M. Alqubali, Marawn Fahad H. Altemani & Abeer Abdulrhman. Basmih · Journal of Pharmaceutical Research International · 2021

Usually, malignant high blood pressure and severe renal damage are main characters in SSc. SRCs is a relatively rare condition, found in approximately 5% of all SSc patients. This study was carried out to summarize the contemporary evidence regarding the causes, risk factors, man...

Open access Research Article 10.9734/jpri/2021/v33i36B31954

Updates in Diagnosis and Managements of Polymyositis: Simple Review

Laila Abdullah S. Alanazi, Abdullah Mohammed A. AL Madshush, Omniyyah Mohammed S. Alatawi, Asmaa Hamed M. Albuhairy, Jomana Khalid M. Aljohani, Asmaa Muslim Alfahimani, Jalawi Talal A. Alotaibi, Abrar Atallah O. Alatawi, Mohammed Ibrahim F. Bin Ibrahim, Saud Mohammed S. Alrofydi & Marwan Fahad H. Altemani · Journal of Pharmaceutical Research International · 2021

Idiopathic inflammatory myopathies (IIMs) includes an unusual group of acute, chronic, and subacute developed diseases of skeletal muscle characterized by moderate to severe muscle weakness and inflammation.Polymyositis is generally considered to be a prototypic T cell-mediated a...

Open access Research Article 10.9734/jpri/2021/v33i41A32323